Hikma Pharma Stock Price, News & Analysis
Company Description
Hikma Pharma (OTC Link: HKMPF) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $5.1B.
HKMPF stock has declined 30.5% over the past year. Shares last traded at $18.72.
This page provides a comprehensive overview of HKMPF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Hikma Pharma (HKMPF) stock last traded at $18.72. Over the past 12 months, the stock has lost 30.5%. At a market capitalization of $5.1B, HKMPF is classified as a mid-cap stock with approximately 217.8M shares outstanding.
Latest News
Hikma Pharma has 9 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 2 with negative movement. Key topics include fda approval, partnership. View all HKMPF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Hikma Pharma (HKMPF) currently stands at 155.7 thousand shares, down 2.9% from the previous reporting period, representing 0.1% of the float. Over the past 12 months, short interest has decreased by 77.8%. This relatively low short interest suggests limited bearish sentiment. With 453.9 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Hikma Pharma (HKMPF) currently stands at 453.9 days, up 948.6% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has decreased 54.6% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 38.5 to 1000.0 days.
HKMPF Company Profile & Sector Positioning
Hikma Pharma (HKMPF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing HKMPF often look at related companies in the same sector, including Hikma Pharmaceuticals Plc (HKMPY), Sumitomo Dainippon Pharma (SMDPY), Procaps Group Sa (PROCF), Almirall (LBTSF), and Almirall SA (ALMRY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate HKMPF's relative position within its industry.